A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
- Posted on January 9, 2026
- By CNBC
- 3 Views
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Europe's best performing stock in 2025, Abivax, could be snapped up any day now, analysts say.
